• Latest Posts
Podcast 10 Nov 2023

How biotech can mend a broken heart

Lilly boosts obesity portfolio with Versanis Bio acquisition

Six companies that have made their name in the cardiovascular space

In Depth 19 May 2023

Can cardiovascular diseases be cured? The future of heart treatment

LincRNA discovery could lead to targeted treatments

Calida Therapeutics launches to tackle thrombo-inflammatory disorders

Destiny Pharma gel reduces nasal staph in surgery patients  

Heartseed and Novo Nordisk dose first patient in heart failure cell therapy study

Possible drug targets from Korean atherosclerosis research